Published in Arthritis Rheum on November 01, 1991
DR-DQ variants in rheumatoid arthritis and Felty's syndrome: comment on the article by Wallin et al. Arthritis Rheum (1992) 1.40
Genetic epidemiology of rheumatoid arthritis. Am J Hum Genet (1995) 1.19
Autoimmunity in Rheumatic Diseases Is Induced by Microbial Infections via Crossreactivity or Molecular Mimicry. Autoimmune Dis (2012) 1.07
HLA-linked rheumatoid arthritis. Am J Hum Genet (1994) 1.03
Rheumatoid arthritis is linked to Proteus--the evidence. Clin Rheumatol (2007) 0.96
Prognostic markers in rheumatoid arthritis and classification of antirheumatic therapies. Drugs (1995) 0.80
Lack of association of T cell receptor V beta 8 polymorphism with rheumatoid arthritis in United Kingdom and Italian white patients. Ann Rheum Dis (1994) 0.77
Antibacterial and antipeptide antibodies in Japanese and Finnish patients with rheumatoid arthritis. Clin Rheumatol (2004) 0.76
Therapy: Gut-mediated autoimmune arthritis treated with antibiotics. Nat Rev Rheumatol (2010) 0.75
T cell genetics and rheumatoid arthritis (RA) Clin Exp Immunol (1998) 0.75
HLA class II and T-cell receptor beta chain polymorphisms in Belgian patients with rheumatoid arthritis: no evidence for disease association with the TCRBC2, TCRBV8 and TCRBV11 polymorphisms. Ann Rheum Dis (1994) 0.75
Greek rheumatoid arthritis patients have elevated levels of antibodies against antigens from Proteus mirabilis. Clin Rheumatol (2016) 0.75
Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology (1997) 10.08
Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology (1998) 9.57
The gene encoding ribosomal protein S19 is mutated in Diamond-Blackfan anaemia. Nat Genet (1999) 6.23
Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity. Neurology (2005) 3.45
Antibody-forming cells in human colostrum after oral immunisation. Nature (1975) 2.76
Differential response of estrogen receptor alpha and estrogen receptor beta to partial estrogen agonists/antagonists. Mol Pharmacol (1998) 2.55
Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity. Proc Natl Acad Sci U S A (2001) 2.35
Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation. J Neuroimmunol (2001) 2.11
HLA-DR15 is associated with lower age at onset in multiple sclerosis. Ann Neurol (2000) 2.05
Cancer risk among patients with multiple sclerosis and their parents. Neurology (2009) 2.03
Ochratoxin A as the cause of spontaneous nephropathy in fattening pigs. Appl Environ Microbiol (1978) 1.86
Multiple sclerosis: a modifying influence of HLA class I genes in an HLA class II associated autoimmune disease. Tissue Antigens (2000) 1.82
HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation. Tissue Antigens (1991) 1.80
Protective factors in milk and the development of the immune system. Pediatrics (1985) 1.73
Increased frequency of autoimmune diseases in patients with primary sclerosing cholangitis. Am J Gastroenterol (2000) 1.67
Shared genetic factors may not explain the raised risk of comorbid inflammatory diseases in multiple sclerosis. Mult Scler (2012) 1.65
CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms. Genes Immun (2001) 1.62
Bone metabolism in endurance trained athletes: a comparison to population-based controls based on DXA, SXA, quantitative ultrasound, and biochemical markers. Calcif Tissue Int (1997) 1.61
Interferon regulatory factor 5 (IRF5) gene variants are associated with multiple sclerosis in three distinct populations. J Med Genet (2008) 1.59
Trial of a method of reducing inappropriate demands on a hospital emergency department. Public Health (1987) 1.59
Time to secondary progression in patients with multiple sclerosis who were treated with first generation immunomodulating drugs. Mult Scler (2012) 1.59
HLA and rheumatoid arthritis. A study of five families. Tissue Antigens (1981) 1.58
Lung and blood T-cell receptor repertoire in extrinsic allergic alveolitis. Eur Respir J (1997) 1.54
Late miscarriage and preterm birth after treatment with clindamycin: a randomised consent design study according to Zelen. BJOG (2006) 1.54
Germ-line polymorphism of TCR genes and disease susceptibility--fact or hypothesis? Immunol Today (1992) 1.53
A glucocorticoid receptor gene marker is associated with abdominal obesity, leptin, and dysregulation of the hypothalamic-pituitary-adrenal axis. Obes Res (2000) 1.52
Genes in the HLA class I region may contribute to the HLA class II-associated genetic susceptibility to multiple sclerosis. Tissue Antigens (2004) 1.47
Role of polyclonal activation in specific immune responses. Relevance for findings of antibody activity in various diseases. Scand J Immunol (1980) 1.46
T-cell receptor alpha chain germline gene polymorphisms in multiple sclerosis. Neurology (1992) 1.43
Antibody production by human colostral cells. I. Immunoglobulin class, specificity, and quantity. Scand J Immunol (1975) 1.43
Maternal smoking during pregnancy and multiple sclerosis amongst offspring. Eur J Neurol (2008) 1.41
Multiple sclerosis in a family on the Faroe Islands. Acta Neurol Scand (2009) 1.38
Neutralizing antibodies against interferon β: fluctuation is modest and titre dependent. Eur J Neurol (2008) 1.37
Primarily chronic progressive and relapsing/remitting multiple sclerosis: two immunogenetically distinct disease entities. Proc Natl Acad Sci U S A (1989) 1.36
Missense mutations in the human glutathione synthetase gene result in severe metabolic acidosis, 5-oxoprolinuria, hemolytic anemia and neurological dysfunction. Hum Mol Genet (1997) 1.36
Restricted V alpha 2.3 gene usage by CD4+ T lymphocytes in bronchoalveolar lavage fluid from sarcoidosis patients correlates with HLA-DR3. Eur J Immunol (1992) 1.35
HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations. Tissue Antigens (1999) 1.35
Autosomal dominant myofibrillar myopathy with arrhythmogenic right ventricular cardiomyopathy linked to chromosome 10q. Ann Neurol (1999) 1.34
Local antibodies in childhood urinary tract infection: a preliminary study. Int Arch Allergy Appl Immunol (1974) 1.33
Identification of the HLA-DRB1*04, -DRB1*07, and -DRB1*09 alleles by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Hum Immunol (1992) 1.31
Immunoglobulin M and G antibody responses to Plasmodium falciparum glutamate-rich protein: correlation with clinical immunity in Gambian children. Infect Immun (1993) 1.31
A sensitive method for specific quantitation of secretory IgA. Scand J Immunol (1977) 1.29
The multiple sclerosis- and narcolepsy-associated HLA class II haplotype includes the DRB5*0101 allele. Tissue Antigens (1995) 1.29
Two genes encoding immune-regulatory molecules (LAG3 and IL7R) confer susceptibility to multiple sclerosis. Genes Immun (2005) 1.28
Associations of markers in 11 obesity candidate genes with maximal weight loss and weight regain in the SOS bariatric surgery cases. Int J Obes (Lond) (2010) 1.27
HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis. Am J Respir Crit Care Med (1997) 1.27
Optic neuritis: prognosis for multiple sclerosis from MRI, CSF, and HLA findings. Neurology (1998) 1.26
Expression of a novel member of estrogen response element-binding nuclear receptors is restricted to the early stages of chorion formation during mouse embryogenesis. Mech Dev (1996) 1.23
Cardiac effects of beta-adrenergic receptor antagonists. Adv Cardiol (1974) 1.23
Human adipose tissue expresses angiotensinogen and enzymes required for its conversion to angiotensin II. J Clin Endocrinol Metab (1998) 1.22
Secretory IgA and IgM antibodies to E. coli O and poliovirus type I antigens occur in amniotic fluid, meconium and saliva from newborns. A neonatal immune response without antigenic exposure: a result of anti-idiotypic induction? Clin Exp Immunol (1986) 1.22
Apoptosis mediators fasL and TRAIL are upregulated in peripheral blood mononuclear cells in MS. Neurology (2000) 1.21
T and B cell responses of Plasmodium falciparum malaria-immune individuals to synthetic peptides corresponding to sequences in different regions of the P. falciparum antigen Pf155/RESA. J Immunol (1989) 1.21
Analysis of intracellular cytokines in CD4+ and CD8+ lung and blood T cells in sarcoidosis. Am J Respir Crit Care Med (2001) 1.19
The urgency of care need and patient satisfaction at a hospital emergency department. Health Care Manage Rev (1992) 1.18
High turnover rate of Escherichia coli strains in the intestinal flora of infants in Pakistan. Epidemiol Infect (1998) 1.18
Expression of functional leptin receptors in the human ovary. J Clin Endocrinol Metab (1997) 1.18
Inadequacy of mucosal IgM antibodies in selective IgA deficiency: excretion of attenuated polio viruses is prolonged. J Clin Immunol (1988) 1.17
Coxarthrosis and farm work: a case-referent study. Am J Ind Med (1997) 1.17
Epstein-Barr virus and multiple sclerosis: interaction with HLA. Genes Immun (2011) 1.17
Intestinal colonization with Enterobacteriaceae in Pakistani and Swedish hospital-delivered infants. Acta Paediatr Scand (1991) 1.16
Regulation of androgen production in cultured human thecal cells by insulin-like growth factor I and insulin. Fertil Steril (1993) 1.16
Conformational transitions of polynucleotides in polymer media. Eur J Biochem (1974) 1.14
Constitutional downregulation of SEMA5A expression in autism. Neuropsychobiology (2006) 1.13
Hypertension in obesity and the leptin receptor gene locus. J Clin Endocrinol Metab (2000) 1.11
Only one DQ-beta restriction fragment pattern of each DR specificity is associated with insulin-dependent diabetes. J Immunol (1986) 1.11
Does 77C-->G in PTPRC modify autoimmune disorders linked to the major histocompatibility locus? Nat Genet (2001) 1.11
Genetic regulation of human anti-malarial antibodies in twins. Proc Natl Acad Sci U S A (1992) 1.11
T-cell receptor variable region gene usage by CD4+ and CD8+ T cells in bronchoalveolar lavage fluid and peripheral blood of sarcoidosis patients. Proc Natl Acad Sci U S A (1994) 1.11
Secretory and serum immunoglobulin class-specific antibodies to poliovirus after vaccination. J Infect Dis (1985) 1.11
The T cell regulator gene SH2D2A contributes to the genetic susceptibility of multiple sclerosis. Genes Immun (2001) 1.11
Assignment of the locus for ichthyosis prematurity syndrome to chromosome 9q33.3-34.13. J Med Genet (2004) 1.10
Plasma levels of 24S-hydroxycholesterol in patients with neurological diseases. Neurosci Lett (2000) 1.08
An international study of the interobserver variation between interpretations of vaginal smear criteria of bacterial vaginosis. APMIS (2002) 1.08
Synovial fluid cytokines in patients with rheumatoid arthritis or other arthritic lesions. Scand J Immunol (1998) 1.08
Sunlight is associated with decreased multiple sclerosis risk: no interaction with human leukocyte antigen-DRB1*15. Eur J Neurol (2012) 1.07
B cell differentiation factor in synovial fluid of patients with rheumatoid arthritis. Immunol Rev (1984) 1.07
Influence of maternal gut flora and colostral and cord serum antibodies on presence of Escherichia coli in faeces of the newborn infant. Acta Paediatr Scand (1976) 1.07
Blockade of chemokine signaling in patients with multiple sclerosis. Neurology (2006) 1.05
Swedish natalizumab (Tysabri) multiple sclerosis surveillance study. Neurol Sci (2011) 1.05
An immunogenetic heterogeneity in multiple sclerosis. J Neurol Neurosurg Psychiatry (1992) 1.04
Secretory antibodies in IgA-deficient and immunosuppressed individuals. J Clin Immunol (1986) 1.02
Studies of Escherichia coli O antigen specific antibodies in human milk, maternal serum and cord blood. Acta Paediatr Scand (1976) 1.02
Lung restricted T cell receptor AV2S3+ CD4+ T cell expansions in sarcoidosis patients with a shared HLA-DRbeta chain conformation. Thorax (2002) 1.02
Increased numbers of T cells recognizing multiple myelin basic protein epitopes in multiple sclerosis. Eur J Immunol (1992) 1.01
The binding of chondroitin sulphate to collagen. FEBS Lett (1975) 1.01
Partial genome scale analysis of gene expression in human adipose tissue using DNA array. Obes Res (2000) 1.01
Familial effects on the clinical course of multiple sclerosis. Neurology (2007) 1.00
Speculations on mechanisms of HLA associations with autoimmune diseases and the specificity of "autoreactive" T lymphocytes. Immunol Rev (1990) 1.00
X-linked agammaglobulinemia and other immunoglobulin deficiencies. Immunol Rev (1994) 1.00
Changes of visual function and visual ability in daily life following cataract surgery. Acta Ophthalmol Scand (1996) 0.99
Growth failure, encephalopathy, and endocrine dysfunctions in two siblings, one with 5-oxoprolinase deficiency. Eur J Pediatr (1997) 0.99
Hospital admission due to infections in multiple sclerosis patients. Eur J Neurol (2013) 0.99
The impact of HLA-A and -DRB1 on age at onset, disease course and severity in Scandinavian multiple sclerosis patients. Eur J Neurol (2007) 0.99